Safety & effectiveness of COVID-19 vaccines: A narrative review
- PMID: 35859436
- PMCID: PMC9552389
- DOI: 10.4103/ijmr.IJMR_474_21
Safety & effectiveness of COVID-19 vaccines: A narrative review
Abstract
There are currently eight vaccines against SARS-CoV-2 that have received Emergency Use Authorization by the WHO that can offer some protection to the world's population during the COVID-19 pandemic. Though research is being published all over the world, public health officials, policymakers and governments are collecting evidence-based information to establish the public health policies. Unfortunately, continued international travel, violations of lockdowns and social distancing, the lack of mask use, the emergence of mutant strains of the virus and lower adherence by a sector of the global population that remains sceptical of the protection offered by vaccines, or about any risks associated with vaccines, hamper these efforts. Here we examine the literature on the efficacy, effectiveness and safety of COVID-19 vaccines, with an emphasis on select categories of individuals and against new SARS-CoV-2 strains. The literature shows that these eight vaccines are highly effective in protecting the population from severe disease and death, but there are some issues concerning safety and adverse effects. Further, booster shots and variant-specific vaccines would also be required.
Keywords: Adverse effect; COVID-19; SARS-CoV-2; clinical trials; efficacy; neutralization potential; risks; safety.
Conflict of interest statement
Similar articles
-
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877. Eur Rev Med Pharmacol Sci. 2021. PMID: 33629336 Review.
-
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic.Expert Rev Vaccines. 2023 Jan-Dec;22(1):1-16. doi: 10.1080/14760584.2023.2143347. Epub 2022 Nov 11. Expert Rev Vaccines. 2023. PMID: 36330971 Review.
-
Immunogenicity and safety of SARS-CoV-2 vaccines in clinical trials.Front Biosci (Landmark Ed). 2021 Nov 30;26(11):1286-1304. doi: 10.52586/5024. Front Biosci (Landmark Ed). 2021. PMID: 34856768 Review.
-
COVID-19 vaccines: concerns beyond protective efficacy and safety.Expert Rev Vaccines. 2021 Aug;20(8):1013-1025. doi: 10.1080/14760584.2021.1949293. Epub 2021 Jul 5. Expert Rev Vaccines. 2021. PMID: 34180347 Review.
-
Recipients of COVID-19 vaccines face challenges of SARS-CoV-2 variants.Int J Biol Sci. 2022 Jul 11;18(12):4642-4647. doi: 10.7150/ijbs.72424. eCollection 2022. Int J Biol Sci. 2022. PMID: 35874950 Free PMC article. Review.
Cited by
-
High-Titer Recombinant Adenovirus 26 Vector GMP Manufacturing in HEK 293 Cells with a Stirred Single-Use Bioreactor for COVID-19 Vaccination Purposes.ACS Omega. 2023 Oct 2;8(40):36720-36728. doi: 10.1021/acsomega.3c03007. eCollection 2023 Oct 10. ACS Omega. 2023. PMID: 37841195 Free PMC article.
-
Impact of COVID-19 vaccination on hospitalization, hospital utilization and expenditure for COVID-19: A retrospective cohort analysis of a South African private health insured population.PLoS One. 2025 Jan 24;20(1):e0317686. doi: 10.1371/journal.pone.0317686. eCollection 2025. PLoS One. 2025. PMID: 39854537 Free PMC article.
-
In-hospital mortality among hospitalized COVID-19 patients in a tertiary care hospital in Dhaka City: a retrospective cohort study.Front Med (Lausanne). 2025 May 20;12:1571865. doi: 10.3389/fmed.2025.1571865. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40463970 Free PMC article.
-
COVID-19 Vaccines Effectiveness and Safety in Trinidad and Tobago: A Systematic Review and Meta-Analysis.Microorganisms. 2025 Jan 10;13(1):135. doi: 10.3390/microorganisms13010135. Microorganisms. 2025. PMID: 39858903 Free PMC article. Review.
-
Impact of COVID-19 Vaccination on Menstrual Irregularities, Bleeding Patterns, and Cycle Duration: A Systematic Review and Meta-Analysis.Health Sci Rep. 2025 Jun 16;8(6):e70882. doi: 10.1002/hsr2.70882. eCollection 2025 Jun. Health Sci Rep. 2025. PMID: 40524715 Free PMC article. Review.
References
-
- World Health Organization. Status of COVID-19 vaccines within WHO EUL/PQ evaluation process. [accessed on December 20, 2021]. Available from: https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVI... .
-
- Dolgin E. CureVac COVID vaccine let-down spotlights mRNA design challenges. Nature. 2021;594:483. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous